Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression

Fig. 3

Survival curve and ROC curve to evaluate the predictive value of LHX9 expression on the prognosis of GC patients. A: box line plot of the difference in LHX9 expression in GC tissues and normal gastric mucosal tissues; B: Kaplan–Meier survival analysis curves of GC patients in the high LHX9 expression group and low LHX9 expression group; C-D: time-dependent ROC curves and and PR curves to evaluate the diagnostic value of LHX9 on the prognosis of GC patients; E: single-factor independent prognostic analysis forest plot; F: multi-factor independent prognostic analysis forest plots; G: survival curves to evaluate the predictive efficacy of LHX9 on PFS in GC patients

Back to article page